Cargando…
Using Prazosin to Treat Posttraumatic Stress Disorder and Associations: A Systematic Review
OBJECTIVE: A central adrenergic hyperactivation is described in the neurobiology of posttraumatic stress disorder (PTSD) with probable variable symptomatic impact. Few studies have evaluated using the alpha-1 adrenergic antagonist prazosin for such symptoms; however, given the likely pathophysiology...
Autores principales: | Paiva, Henrique Soares, Filho, Idiberto José Zotarelli, Cais, Carlos Filinto da Silva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169333/ https://www.ncbi.nlm.nih.gov/pubmed/33979949 http://dx.doi.org/10.30773/pi.2020.0411 |
Ejemplares similares
-
Prazosin initiation and dose titration in a patient with posttraumatic stress disorder on concurrent carvedilol
por: Khaw, Chelsea, et al.
Publicado: (2019) -
Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation
por: Naoum, Flávio Augusto, et al.
Publicado: (2017) -
Case report: Prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder
por: Guo, Ping, et al.
Publicado: (2022) -
Major Predictors of Incidence of Congestive Heart Failure and the Responsive Character of Enteral Nutrition: Meta-Analysis
por: Ramirez, Ana Valeria Garcia, et al.
Publicado: (2018) -
Prazosin for Trauma Nightmares and Sleep Disturbances in Combat Veterans with Post-Traumatic Stress Disorder
por: Khazaie, Habibolah, et al.
Publicado: (2016)